European guidelines for quality assurance in cervical cancer screening: Recommendations for clinical management of abnormal cervical cytology, part 1

Cytopathology

Volumn 19, Issue 6, 2008, Pages 342-354

  Jordan, J ^a,j   Arbyn, M ^b   Martin Hirsch, P ^c   Schenck, U ^d   Baldauf, J J ^e   Da Silva, D ^f   Anttila, A ^g   Nieminen, P ^h   Prendiville, W ⁱ  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c ROYAL PRESTON HOSPITAL   (United Kingdom)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f Centro de Histocompatibilidade de Coimbra   (Portugal)

^g FINNISH CANCER REGISTRY   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ Pathology Research Laboratory   (Ireland)

^j NONE   (United Kingdom)

more..

Author keywords

Cervical cancer screening; Cervical intraepithelial neoplasia; Clinical management; Colposcopy; European guidelines; Human papillomavirus testing; The Bethesda system

Indexed keywords

ESTROGEN;

CANCER CELL; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER SCREENING; CELL TRANSFORMATION; COLPOSCOPY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDOMETRIUM CELL; FOLLOW UP; GYNECOLOGY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL DECISION MAKING; NOMENCLATURE; PATIENT REFERRAL; POSTMENOPAUSE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; PUERPERIUM; QUALITY CONTROL; REVIEW; SQUAMOUS CELL; SQUAMOUS INTRAEPITHELIAL LESION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; VAGINA; VAGINA EPITHELIUM; VIRUS INFECTION; VULVA; WART VIRUS;

BIOPSY; CERVIX UTERI; COLPOSCOPY; EUROPEAN UNION; FEMALE; GUIDELINES AS TOPIC; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; QUALITY CONTROL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 56549095399     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2008.00623.x     Document Type: Review

References (66)

1. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002 287 : 2114 9.
2. Herbert A, Bergeron C, Wiener H et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology 2007 18 : 213 9.
3. Arbyn M, Herbert A, Schenck U et al. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology 2007 18 : 133 9.
4. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995 85 : 202 10.
5. Arbyn M, Buntinx F, Van Ranst M et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004 96 : 280 93.
6. Arbyn M, Dillner J, Van Ranst M et al. Re: Have we resolved how to triage equivocal cervical cytology? J Natl Cancer Inst 2004 96 : 1401 2.
7. Hinselmann H. Verbesserung der Inspektionsm"glichkeiten von Vulva, Vagina und Portio. Munch Med Wochenschr 1925 72 : 1733 42.
8. Jordan JA. Colposcopy in the diagnosis of cervical cancer and precancer. Clin Obstet Gynecol 1985 12 : 67 76.
9. Sellors JW, Sankaranarayanan R. Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginners' Manual. Lyon : IARC 2003 : 1 132.
10. Walker P, Dexeus S, De Palo G et al. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2003 101 : 175 7.
11. Prendiville W, Ritter J, Tatti S, Twiggs L. Colposcopy: Management Options. Edinburgh : Saunders 2003 : 1 213.
12. Prendiville W. The treatment of grade 3 cervical intraepithelial neoplasia. In : Colposcopy: Management Options. Prendiville W, Ritter J, Tatti S, Twiggs LB (eds). Edinburgh : Saunders 2003 : pp. 129 33.
13. Mor-Yosef S, Lopes A, Pearson S, Monaghan M. Loop diathermy cone biopsy. Obstet Gynecol 1990 73 : 884 6.
14. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998 91 : 626 31.
15. Pretorius RG, Belinson JL, Zhang WH et al. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?. J Reprod Med 2001 46 : 724 8.
16. Pretorius RG, Zhang WH, Belinson JL et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004 191 : 430 4.
17. NHSCSP. Standards and quality in colposcopy. In : NHS Cancer Screening Programmes, Vol. 2. Luesley D (ed.). Sheffield : NHSCSP Publications 1996 : pp. 1 27.
18. NHSCSP. The Colposcopy Examination. London : Cancer Research UK 1996.
19. NHSCSP. Guidance notes on the safe use of diathermy loop excision for the treatment of cervical intraepithelial neoplasia. In : NHS Cancer Screening Programmes, Vol. 4. Hancock CW (ed.). NHSCSP, Sheffield : NHSCSP Publications 1997 : pp. 1 10.
20. NHSCSP. Colposcopy and programme management: guidelines for the NHS Cervical Screening Programme. In : NHS Cancer Screening Programmes, Vol. 20. Luesley D, Leeson S (eds). Sheffield, Manor House : NHSCSP publication 2004 : pp. 1 80.
21. Martin M, Prendiville W. Is local anaesthetic infiltration less painful than cervical punch biopsy. A study comparing the amount of pain felt by women attending a colposcopy clinic who required a cervical punch biopsy. In : Annual Meeting. British Society of Colposcopy and Cervical Pathology (ed.). Edinburgh : BSCCP 2004.
22. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 2001 61 : 192 6.
23. Cartier R, Cartier I. Practical Colposcopy, 3rd edn. Paris : Laboratoire Cartier 1993.
24. Prendiville W, Davies R, Berry PJ. A low voltage diathermy loop for taking cervical biopsies. A qualitative comparison with punch biopsy forceps. Br J Obstet Gynaecol 1986 93 : 773 6.
25. Anderson MC, Jordan JA, Morse AR, Sharpe F. Integrated Colposcopy, 2nd edn. London : Chapman and Hall 1996.
26. Ismail SM, Colclough AB, Dinnen JS et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989 298 : 707 10.
27. Stoler MH, Schiffman MA. Interobserver reproducibility of cervical cytologic and histologic interpretations. JAMA 2001 285 : 1500 5.
28. Horvat R, Jordan J, Herbert A, Wiener H. Chapter 5: Techniques and quality assurance guidelines for histopathology. In : European Guidelines for Quality Assurance in Cervical Cancer Screening. Arbyn M, Anttila A, Jordan J et al. (eds). Luxembourg : Office for Official Publications of the European Communities 2008 : pp. 173 89.
29. Weitzman GA, Korhonen MO, Reeves KO et al. Endocervical brush cytology. An alternative to endocervical curettage?. J Reprod Med 1988 33 : 677 83.
30. Andersen W, Frierson H, Barber S et al. Sensitivity and specificity of endocervical curettage and the endocervical brush for the evaluation of the endocervical canal. Am J Obstet Gynecol 1988 159 : 702 7.
31. Hoffman MS, Sterghos S Jr., Gordy LW, Gunasekar D. Evaluation of the cervical canal with the endocervical brush. Obstet Gynecol 1993 82 : 573 7.
32. Mogensen ST, Bak M, Dueholm M et al. Cytobrush and endocervical curettage in the diagnosis of dysplasia and malignancy of the uterine cervix. Acta Obstet Gynecol Scand 1997 76 : 69 73.
33. Gath DH, Hallam N, Mynors-Wallis L, Day A, Bond SAK. Emotional reactions in women attending a UK colposcopic clinic. J Epidemiol Community Health 1995 49 : 79 83.
34. Wright TC, Cox JT, Massad LS, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002 287 : 2120 9.
35. Anttila A, Ronco G, Lynge E et al. Chapter 2: Epidemiological guidelines for quality assurance in cervical cancer screening. In : European Guidelines for Quality Assurance in Cervical Cancer Screening. Arbyn M, Anttila A, Jordan J et al. (eds). Luxembourg : Office for Official Publications of the European Communities 2008 : pp. 11 52.
36. Arbyn M, Dillner J, Schenck U et al. Chapter 3: Methods for screening and diagnosis. In : European Guidelines for Quality Assurance in Cervical Cancer Screening. Arbyn M, Anttila A, Jordan J et al. (eds). Luxembourg : Office for Official Publications of the European Communities 2008 : pp. 69 152.
37. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions : a meta-analysis. Obstet Gynecol 1998 92 : 727 35.
38. Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002 9 : 86 91.
39. ASCUS-LSIL Triage Study Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003 188 : 1383 92.
40. Morin C, Bariati C, Bouchard C et al. Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med 2001 46 : 799 805.
41. Solomon D, Schiffman MA, Tarone B. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance (ASCUS): baseline results from a randomized trial. J Natl Cancer Inst 2001 93 : 293 9.
42. Arbyn M, Sasieni P, Meijer CJ et al. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006 24 (Suppl. 3 78 89.
43. Cox JT, Schiffman MA, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003 188 : 1406 12.
44. Guido R, Schiffman MA, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003 188 : 1401 5.
45. Cuzick J, Szarewski A, Cubie H et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003 362 : 1871 6.
46. Coleman D, Day N, Douglas G et al. European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme. Eur J Cancer 1993 29A (Suppl. 4 S1 38.
47. Sawaya GF. A 21-year-old woman with atypical squamous cells of undetermined significance. JAMA 2005 294 : 2210 8.
48. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999 91 : 252 8.
49. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN. An update of pooled evidence. Gynecol Oncol 2005 99 (Suppl. 3 7 11.
50. Bergeron C, Jeannel D, Poveda J, Cassonnet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000 95 : 821 7.
51. Ferris DG, Wright TC Jr., Litaker MS et al. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract 1998 46 : 136 41.
52. Nobbenhuis MAE, Walboomers JM, Helmerhorst TJM et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999 354 : 20 5.
53. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001 358 : 1782 3.
54. Remmink AJ, Walboomers JM, Helmerhorst TJM et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995 61 : 306 11.
55. Van Duin M, Snijders PJ, Schrijnemakers HF et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002 98 : 590 5.
56. Schlecht NF, Platt RW, Duarte-Franco E et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003 95 : 1336 43.
57. ASCUS-LSIL Triage Study Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003 188 : 1393 400.
58. Kurman RJ, Henson DE, Herbst AL et al. Interim guidelines for management of abnormal cervical cytology. JAMA 1994 271 : 1866 9.
59. Taylor RR, Guerrieri JP, Nash JD, Henry MR, O'Connor DM. Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. J Reprod Med 1993 38 : 443 7.
60. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998 91 : 278 82.
61. Kennedy AW, Salmieri SS, Wirth SL et al. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996 63 : 14 8.
62. Ronnett BM, Manos M, Ransley JE et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999 30 : 816 25.
63. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system. Am J Obstet Gynecol 1997 177 : 1188 95.
64. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer 2000 90 : 207 14.
65. Valdini A, Vaccaro C, Pechinsky G, Abernathy V. Incidence and evaluation of an AGUS Papanicolaou smear in primary care. J Am Board Fam Pract 2001 14 : 172 7.
66. Kim TJ, Kim HS, Park CT et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999 73 : 292 8.